Klm Labs Pvt Company Profile
What is the competitive landscape for KLM LABS PVT
KLM LABS PVT has two approved drugs.
Summary for Klm Labs Pvt
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Klm Labs Pvt
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Klm Labs Pvt | MESALAMINE | mesalamine | ENEMA;RECTAL | 220016-001 | Mar 31, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Klm Labs Pvt | DOCOSANOL | docosanol | CREAM;TOPICAL | 220017-001 | Jul 31, 2026 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
